{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/hepatitis-b/diagnosis/when-to-test-for-hepatitis-b/","result":{"pageContext":{"chapter":{"id":"6acbd5e1-b0e6-527b-bad0-42c21a928d1e","slug":"when-to-test-for-hepatitis-b","fullItemName":"When to test for hepatitis B","depth":2,"htmlHeader":"<!-- begin field f45250b8-c836-4c9f-b74f-ae75370afa18 --><h2>When should I test for hepatitis B?</h2><!-- end field f45250b8-c836-4c9f-b74f-ae75370afa18 -->","summary":"","htmlStringContent":"<!-- begin item 5d523eba-2166-4795-9659-080e1d71e3a3 --><!-- begin field 3e4ce80e-914a-4bcc-b652-19372116355b --><p><strong>Consider hepatitis B <a class=\"topic-reference internal-reference\" href=\"/topics/hepatitis-b/diagnosis/how-to-test-for-hepatitis-b/\">serology</a> in the following groups:</strong></p><ul><li><strong>People who are asymptomatic who are <a class=\"topic-reference internal-reference\" href=\"/topics/hepatitis-b/background-information/people-at-high-risk-of-hepatitis-b/\">at high risk of hepatitis B</a> infection. </strong> In particular screen opportunistically those who:<ul><li>Are more likely to have been exposed to hepatitis B (such as immigrants from areas with a high prevalence, injecting drug users, and sex workers).</li><li>Have been sexually assaulted.</li><li>Have sustained a needlestick injury.</li><li>Are HIV-positive.</li></ul></li><li><strong>People with clinical features </strong><strong>that could be indicative of hepatitis B:</strong><ul><li><strong>For acute infection, these include:</strong><ul><li>A prodromal illness that includes fever, arthralgia, or a rash (that may appear about 2 weeks before the onset of jaundice, then resolves in acute hepatitis B).</li><li>Non-specific malaise, fatigue, fever, nausea, and poor appetite.</li><li>Right upper quadrant abdominal pain.</li><li>Jaundice (with dark urine and/or pale stools if cholestasis).</li><li>Extrahepatic manifestations such as glomerulonephritis, vasculitis, and polyarteritis.</li><li>Note: Acute hepatitis B infection is asymptomatic in almost all infants and children, 10-50% of adults, and is especially likely in people with HIV.</li></ul></li><li><strong>For chronic infection, there are often no physical signs.</strong> After many years of infection, depending on the severity and duration, there may be signs of chronic liver disease including:<ul><li>Spider naevi.</li><li>Finger clubbing.</li><li>Jaundice.</li><li>Hepatosplenomegaly. </li><li>In severe cases thin skin, bruising, ascites, liver flap and encephalopathy.</li></ul></li></ul></li><li><strong>People with abnormal liver function tests:</strong><ul><li><strong>In acute hepatitis B:</strong><ul><li>Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels may be significantly increased (usually between 500 and 10,000 IU/L).</li><li>Bilirubin may be elevated (usually between 85.5 and 171 micromols/L but can reach up to 500 micromols/L).</li><li>Alkaline phosphatase is generally < 2x the upper limit of normal, but higher if there is cholestasis.</li><li>Prothrombin time may be prolonged (5 seconds or more suggests severe hepatitis and 50 seconds or more suggests acute liver failure).</li></ul></li><li><strong>In chronic hepatitis B</strong>, in most people the only abnormality will be mildly elevated serum aminotransferase levels; in many, liver enzymes will be normal.</li></ul></li></ul><!-- end field 3e4ce80e-914a-4bcc-b652-19372116355b --><!-- end item 5d523eba-2166-4795-9659-080e1d71e3a3 -->","topic":{"id":"f75dcfde-3cb4-5059-94df-19d53a6c28e9","topicId":"4fc86266-0752-4667-994f-7f6fc7e46056","topicName":"Hepatitis B","slug":"hepatitis-b","lastRevised":"Last revised in November 2019","chapters":[{"id":"986057cd-07a1-565e-9c7a-d3b3dc88368d","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"2331f5c5-fb51-54d1-b722-946b4f34a693","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"653459fe-510a-5a1a-92dc-8197c598c85e","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"12e8fb8c-9424-5f20-90e5-65e823f603c3","slug":"changes","fullItemName":"Changes"},{"id":"2299e2ba-3fb3-5f37-9c6b-63ec8dbbffd6","slug":"update","fullItemName":"Update"}]},{"id":"c14d3383-629b-5bd6-b6c0-318bbcf86fb2","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"58e5cd67-9ca7-5bfe-b2b6-bf4372ac895f","slug":"goals","fullItemName":"Goals"},{"id":"a1abbdfd-238b-55b7-8de2-09fd4ff6065b","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"fc44420e-13ab-526e-a0c7-ef2f93cce77b","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"b59d4642-5914-585b-82b1-6f7989cef100","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"af246587-2615-513e-aafc-3ea762d8aab7","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"bba17b9f-47f8-52cf-a8e7-111c1a5094a2","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"2c6fa000-50a2-5823-9acb-0bd808dc51e6","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"dfcb6ed4-783a-5fbc-9259-096762bb7c69","slug":"definition","fullItemName":"Definition"},{"id":"e06f78dc-080c-542f-b450-356db08c00a9","slug":"prevalence","fullItemName":"Prevalence"},{"id":"0c1d15cf-36ee-5c84-ad7c-e06836a161c0","slug":"transmission","fullItemName":"Transmission"},{"id":"939f1d6a-6b15-5c4f-91c8-9164e800cd87","slug":"people-at-high-risk-of-hepatitis-b","fullItemName":"People at high risk of hepatitis B"},{"id":"d452f04a-7d9d-5739-9cb9-f583eb136f3a","slug":"complications-prognosis","fullItemName":"Complications and prognosis"}]},{"id":"b3642d36-7175-548b-b6f0-d694e7397bd3","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"6acbd5e1-b0e6-527b-bad0-42c21a928d1e","slug":"when-to-test-for-hepatitis-b","fullItemName":"When to test for hepatitis B"},{"id":"706362c9-e255-511b-83b4-74b853c926c7","slug":"how-to-test-for-hepatitis-b","fullItemName":"How to test for hepatitis B"},{"id":"c0c1ae56-2316-56eb-ad65-4b85e982fc11","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"41c2681f-bf40-5b08-a518-32f2ab1206fb","fullItemName":"Management","slug":"management","subChapters":[{"id":"b2d949a2-a42f-5c0a-a955-414bac741bd3","slug":"prevention-of-infection-with-hepatitis-b","fullItemName":"Scenario: Prevention of infection with Hepatitis B"},{"id":"00ed825c-5927-50f5-940d-94d6b4001150","slug":"managing-hepatitis-b-infection","fullItemName":"Scenario: Managing hepatitis B infection"}]},{"id":"c7941282-a3b2-5716-b0cc-80cb243a7405","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"8df28bde-0bc5-533e-a54b-507fd3ceee61","slug":"hepatitis-b-vaccine","fullItemName":"Hepatitis B vaccine"},{"id":"c7099851-c102-56f2-b063-021f3d00b880","slug":"analgesics","fullItemName":"Analgesics"},{"id":"6a9675fd-5496-5ca4-9a76-36ee6cc93a25","slug":"anti-emetics","fullItemName":"Anti-emetics"},{"id":"1576eb24-e96c-50e6-9976-05164be1127e","slug":"anti-pruritics","fullItemName":"Anti-pruritics"}]},{"id":"3c7651c1-b246-51db-85b3-e1b6713a47bd","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"548463b9-9c49-5154-bad9-fe10668804da","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"8b3032fc-e20a-509b-b390-81cef2509ded","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"5e0cdb38-e518-5a0c-9215-493c78f74377","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"3e63144c-a0f3-5eb1-980d-a219e8a53633","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"94d851c4-3314-5a3d-801a-0a208e287514","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"4df2edc1-d17c-57d1-a914-4100299c8f7d","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"cecf6c0b-d134-54cb-abef-c2ccab9effb6","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"b3642d36-7175-548b-b6f0-d694e7397bd3","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"d0ccc819-90dc-5cc3-8d2a-2b906299626c","slug":"basis-for-recommendation-d85","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 0d6d825f-691c-4711-9ad0-87ea01ff3ec9 --><h3>Basis for recommendation</h3><!-- end field 0d6d825f-691c-4711-9ad0-87ea01ff3ec9 -->","summary":null,"htmlStringContent":"<!-- begin item d85ae260-88a2-45da-855c-0f830d41f6be --><!-- begin field 45ff1a5a-1119-4b97-a144-e9a2296f3e47 --><p>The recommendations on testing for hepatitis B are based on expert opinion the British Liver Trust guidelines <em>A professional's guide to hepatitis B </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/hepatitis-b/references/\">British Liver Trust, 2009</a>] and <em>Hepatitis B infection and immunisation in primary care</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hepatitis-b/references/\">British Liver Trust, 2017</a>], the British Association of Sexual Health and HIV (BASHH) guideline <em>2017 interim update of the 2015 BASHH National Guidelines for the Management of the Viral Hepatitides </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/hepatitis-b/references/\">BASHH, 2017</a>], the National Institute of Health and Care Excellence (NICE) public health guideline <em>Hepatitis B and C testing: people at risk of infection </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/hepatitis-b/references/\">NICE, 2013</a>], the BMJ Best Practice guideline Hepatitis B [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hepatitis-b/references/\">BMJ Best Practice, 2018</a>], and are also consistent with the opinions of previous expert reviewers of this CKS topic.</p><!-- end field 45ff1a5a-1119-4b97-a144-e9a2296f3e47 --><!-- end item d85ae260-88a2-45da-855c-0f830d41f6be -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}